NCT02248844已完成不适用
Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 667
- 试验地点
- 1
- 主要终点
- Number of Participants with Adverse Events
研究概览
简要总结
This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject and Investigator decision to treat crow's feet lines with Botox®
排除标准
- 未提供
结局指标
主要结局
Number of Participants with Adverse Events
时间窗: Up to 3 months
次要结局
- Investigator's Assessment of Change in Appearance of Crow's Feet Lines on a 3-Point Scale(Baseline, Up to 3 months)
- Subject's Assessment of Change in Appearance of Crow's Feet Lines on a 7-Point Scale(Baseline, Up to 3 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in KoreaMuscle SpasticityGlabellar LinesHyperhidrosisNCT02043145Allergan727
已完成
不适用
Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in KoreaUrinary IncontinenceUrinary Bladder, OveractiveNCT02010788Allergan523
已完成
不适用
Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in KoreaMigraine DisordersHeadacheNCT01976611Allergan402
已完成
4 期
A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic MigraineMigraine DisordersNCT02147561Allergan280
已完成
不适用
A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in IndiaUrinary IncontinenceOveractive BladderNCT02590250Allergan250